Skip to main content

barr 250 mg 1075 Pill - white capsule/oblong

Pill with imprint barr 250 mg 1075 is White, Capsule/Oblong and has been identified as Temozolomide 250 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for barr 250 mg 1075

Temozolomide 250 mg barr 250 mg 1075
Temozolomide 250 mg barr 250 mg 1075


barr 250 mg 1075
250 mg
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-7602 (Discontinued)
Inactive Ingredients
lactose anhydrous, silicon dioxide, povidone k30, sodium starch glycolate type A potato, stearic acid, tartaric acid, D&C Yellow No. 10, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, titanium dioxide, ferrosoferric oxide, aluminum oxide, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, propylene glycol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.